Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3347-3356

  Hu, Yanxin ^a   Jin, Yi ^a,c   Han, Deping ^a   Zhang, Guozhong ^a   Cao, Shanping ^a   Xie, Jingjing ^a   Xue, Jia ^a   Li, Yi ^a   Meng, Di ^a   Fan, Xiaoxu ^a   Sun, Lun Quan ^b   Wang, Ming ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c BEIJING FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTAMINE; KETOTIFEN; OSELTAMIVIR; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME RELEASE; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LUNG INJURY; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; FEMALE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LUNG INJURY; MAST CELLS; MICE; MICE, INBRED BALB C;

MUS; ORTHOMYXOVIRIDAE;

EID: 84863275737     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06053-11     Document Type: Article

References (49)

1. Aoyagi M, Shimojo N, Sekine K, Nishimuta T, Kohno Y. 2003. Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin. Exp. Immunol. 131:312-317.
2. Bayram H, et al. 1999. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J. Allergy Clin. Immunol. 104:93-99.
3. Bechi P, et al. 1995. Gastric mucosal histamine storing cells. Evidence for different roles of mast cells and enterochromaffin-like cells in humans. Dig. Dis. Sci. 40:2207-2213.
4. Bradding P, Walls AF, Holgate ST. 2006. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117:1277-1284.
5. Carter MJ. 2007. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J. Med. Microbiol. 56:875- 883.
6. Chan MC, et al. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6:135.
7. Chen H, et al. 2006. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl. Acad. Sci. U. S. A. 103:2845-2850.
8. Cheung CL, et al. 2006. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 193:1626 -1629.
9. Cheung CY, et al. 2002. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360:1831-1837.
10. Dawicki W, Marshall JS. 2007. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 19:31-38.
11. de Jong MD, et al. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672.
12. Du N, et al. 2010. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J. Virol. 84:7822-7831.
13. Echtenacher B, Mannel DN, Hultner L. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77.
14. Furuta T, Kikuchi T, Iwakura Y, Watanabe N. 2006. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J. Immunol. 177:3294 -3302.
15. Gaboury JP, Johnston B, Niu XF, Kubes P. 1995. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J. Immunol. 154:804-813.
16. Galli SJ, Nakae S, Tsai M. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6:135-142.
17. Gibbons AE, Price P, Robertson TA, Papadimitriou JM, Shellam GR. 1990. Replication of murine cytomegalovirus in mast cells. Arch. Virol. 115:299 -307.
18. Guan Y, et al. 2004. H5N1 influenza: a protean pandemic threat. Proc. Natl. Acad. Sci. U. S. A. 101:8156-8161.
19. He S, Gaca MD, Walls AF. 1998. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J. Pharmacol. Exp. Ther. 286:289 -297.
20. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
21. Hu Y, et al. 2007. Effects of chronic heat stress on immune responses of the foot-and-mouth disease DNA vaccination. DNA Cell Biol. 26:619- 626.
22. Ilyushina NA, et al. 2008. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob. Agents Chemother. 52:3889 -3897.
23. Ilyushina NA, Hoffmann E, Salomon R, Webster RG, Govorkova EA. 2007. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir. Ther. 12:363-370.
24. Jolly S, Detilleux J, Desmecht D. 2004. Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet. Immunol. Immunopathol. 97:125-136.
25. Kilpatrick AM, et al. 2006. Predicting the global spread of H5N1 avian influenza. Proc. Natl. Acad. Sci. U. S. A. 103:19368 -19373.
26. King CA, Marshall JS, Alshurafa H, Anderson R. 2000. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J. Virol. 74:7146 -7150.
27. Korteweg C, Gu J. 2008. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172: 1155-1170.
28. Lee DC, et al. 2005. p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J. Virol. 79:10147-10154.
29. Li X, McKinstry KK, Swain SL, Dalton DK. 2007. IFN-gamma acts directly on activated CD4+T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 179:939 -949.
30. McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA. 2007. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg. Infect. Dis. 13:1354 -1357.
31. Metcalfe DD, Baram D, Mekori YA. 1997. Mast cells. Physiol. Rev. 77:1033-1079.
32. Metz M, Siebenhaar F, Maurer M. 2008. Mast cell functions in the innate skin immune system. Immunobiology 213:251-260.
33. Minami M, et al. 2002. Role of IFN-gamma and tumor necrosis factoralpha in herpes simplex virus type 1 infection. J. Interferon Cytokine Res. 22:671- 676.
34. Orinska Z, et al. 2005. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106:978 -987.
35. Palese P. 2004. Influenza: old and new threats. Nat. Med. 10:S82-S87.
36. Puissant-Lubrano B, et al. 2010. Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans. J. Clin. Invest. 120:1636 -1644.
37. Salomon R, Hoffmann E, Webster RG. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. U. S. A. 104:12479 -12481.
38. Shirato K, Taguchi F. 2009. Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology 386:88 -93.
39. Spender LC, Hussell T, Openshaw PJ. 1998. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease. J. Gen. Virol. 79:1751-1758.
40. St John AL, et al. 2011. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. U. S. A. 108:9190 -9195.
41. Sun QH, Peng JP, Xia HF, Yang Y. 2007. IFN-gamma promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells. J. Interferon Cytokine Res. 27:567-578.
42. Sundstrom JB, Little DM, Villinger F, Ellis JE, Ansari AA. 2004. Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172:4391- 4401.
43. Szretter KJ, et al. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81:2736 -2744.
44. Uiprasertkul M, et al. 2005. Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11:1036 -1041.
45. Wang D, et al. 2008. Mast cell mediated inflammatory response in chickens after infection with very virulent infectious bursal disease virus. Vet. Immunol. Immunopathol. 124:19 -28.
46. Wong SS, Yuen KY. 2006. Avian influenza virus infections in humans. Chest 129:156 -168.
47. Xu T, et al. 2006. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care Med. 174: 1011-1017.
48. Zhao Y, et al. 2008. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clin. Infect. Dis. 47:1575- 1578.
49. Zhou Y, Weyman CM, Liu H, Almasan A, Zhou A. 2008. IFN-gamma induces apoptosis in HL-60 cells through decreased Bcl-2 and increased Bak expression. J. Interferon Cytokine Res. 28:65-72.